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Patients with bronchial asthma usually land up for 
surgery and pose a significant challenge as far as 
their anesthetic management is concerned. Most of 
these patients either take medicines or else are in a 
comparatively controlled state. Different protocols 
have been suggested for such cases such as 
corticosteroids, long-term β2 agonists, leukotriene 
receptor antagonists and theophylline sustained-
release preparations (1). 
Likewise, different anesthetic regimens have been 
forwarded to obviate any acute exacerbation of the 
asthmatic state which if evolves would 
undoubtedly bring in its wake a reduction in chest 
wall and lung compliance coupled with high peak 
airway pressures and a drastic reduction in oxygen 
saturation, alveolar arterial pressure and a 
concomitant increase in partial pressure of carbon 
dioxide. Such events eventually lead to either 
cancellation of surgery or else morbidity. During 
the last two decades, we have been routinely using 
promethazine 25 mg along with meperidine 50 mg 
intravenously as premedication in addition to 
fentanyl and midazolam immediately before the 
induction of anesthesia for all established but 
controlled cases of asthma. Using this protocol, we 
have never encountered any relapse of an 
asthmatic attack during surgery. 
Promethazine, a member of the phenothiazine 
group of drugs is being used as a premedicant in 
anesthesia specially in those cases where an 
allergic component is forthcoming, because not 
only does this drug possesses sedative and 
hypnotic properties but at the same time has 
proven and obvious antihistaminic properties and 
anticholinergic effect (2-4). Again, it has been 
emphasized that promethazine possesses strong 
anticholinergic properties, blocking the responses 
to acetylcholine that are mediated by muscarinic 
receptors (4). Most of the opioids lead to 
bronchoconstriction and thus inevitably worsen 
pre-existing airway disease. It is an established fact 
that acetylcholine released by vagal stimulation 
induces smooth muscle contraction of the airways 
as it binds to the muscarinic receptors (5). Thus the 
cholinergic tone mediated through the vagal nerve 
can be substantially mitigated by using 
anticholinergic, and to serve this purpose 
meperidine stands unique in possessing both 
anticholinergic and analgesic effects. Our 
hypothesis is based on the valid assumption that 
promethazine is a bronchial dilator and 
meperidine has an atropine-like action. 
It has been reported in the literature that 
meperidine could lead to histamine release and 
thus cause a reduction in systemic vascular 
resistance and blood pressure. However, this 
histamine releasing property attributed to 
meperidine can be prevented with the 
administration of H1 and H2 blockers (6). In our 
cocktail, we utilized both meperidine and 
promethazine in asthmatics. Promethazine in this 
combination could obviously prevent and offset the 
histamine releasing effect of meperidine owing to 
its H1 blocking effect and anticholinergic property. 
Meperidine in this combination exerted a 
meaningful vagolytic action and hence broncho-
dilatation and the combined effects thus obtained 
provided significant improvement in the 
pulmonary function of asthmatic patients 
undergoing surgery. The vagolytic potential of 
meperidine as stressed upon in our interim report 
has also been unequivocally substantiated in other 
studies as well (7). Most of the opioids supposedly 
lead to bronchoconstriction and thus worsen 
preexisting airway disease as they are histamine 
releasers (8). Meperidine however stands unique 
because of its anticholinergic properties providing 
bronchiolar dilatation and a substantial reduction 
of bronchial secretions. Experimental data 
conducted also suggest that triggering some of the 
opioid receptors may in fact decrease 
bronchoconstriction. Bronchoconstriction caused 
by citric acid given to guinea pigs was decreased 
when parenteral and inhaled opioids were given 
(9). Although these data do not nullify the 
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histamine releasing properties of opioids, 
nevertheless among the available opioids, 
meperidine has an anticholinergic property and on 
that basis appears to be of value in asthmatics by 
curtailing bronchial secretions and eliciting 
broncho-dilatation. 
Thus this cocktail that we utilized in our patients 
could effectively help in counteracting an acute 
exacerbation of an asthmatic attack both intra and 
postoperatively. During our management of 
chronic asthmatics with this protocol, we have 
never witnessed any change in the lung compliance 
or an increase in peak-airway pressures. Although 
we have not conducted a randomized controlled 
trial in comparing this anesthetic regimen but are 
of the opinion that such a protocol of promethazine 
and meperidine if used in future studies would 
prove to be fruitful owing to the safe 
pharmacokinetic profile of the drugs. 
We may conclude that as purported in the 
literature, meperidine possesses an atropine-like 
action or a vagolytic action thus facilitating 
broncho-dilatation. This broncho-dilatation 
coupled with the H1-blocking and anticholinergic 
effects of promethazine could safely stave off any 
broncho-constrictive effects as a result of 
meperidine owing to its histamine releasing 
property. 
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